| Title | Clinical Pharmacology in Drug Development |
| Abbreviation | Clin. Pharmacol. Drug Dev. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmaceutical Science (Q2); Pharmacology (medical) (Q2) |
| h-index | 35 |
| Overall Rank/Ranking | 8524 |
| SCImago Journal Rank (SJR) | 0.626 |
| Impact Score | 1.86 |
| Publisher | Wiley-Blackwell |
| Country | United States |
| ISSN | 21607648, 2160763X |
| Best Quartile | Q2 |
| Coverage History | 2012-2023 |
Clinical Pharmacology in Drug Development is a journal covering the technologies/fields/categories related to Pharmaceutical Science (Q2); Pharmacology (medical) (Q2). It is published by Wiley-Blackwell. The overall rank of Clinical Pharmacology in Drug Development is 8524. According to SCImago Journal Rank (SJR), this journal is ranked 0.626. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 35. The best quartile for this journal is Q2.
The ISSN of Clinical Pharmacology in Drug Development journal is 21607648, 2160763X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Clinical Pharmacology in Drug Development is cited by a total of 753 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Clinical Pharmacology in Drug Development is 1.86, which is computed in 2024 as per its definition. Clinical Pharmacology in Drug Development IF is decreased by a factor of 0.29 and approximate percentage change is -13.49% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Clinical Pharmacology in Drug Development is 1.86. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.86 |
| 2022 | 2.15 |
| 2021 | 2.13 |
| 2020 | 1.92 |
| 2019 | 1.79 |
| 2018 | 2.13 |
| 2017 | 1.34 |
| 2016 | 0.87 |
| 2015 | 1.18 |
| 2014 | 1.26 |
Clinical Pharmacology in Drug Development has an h-index of 35. It means 35 articles of this journal have more than 35 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Clinical Pharmacology in Drug Development is 21607648, 2160763X. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Clinical Pharmacology in Drug Development is 8524. According to SCImago Journal Rank (SJR), this journal is ranked 0.626. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.626 |
| 2022 | 0.637 |
| 2021 | 0.531 |
| 2020 | 0.711 |
| 2019 | 0.494 |
| 2018 | 0.573 |
| 2017 | 0.430 |
| 2016 | 0.455 |
| 2015 | 0.382 |
| 2014 | 0.463 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 8524 |
| 2022 | 7999 |
| 2021 | 9414 |
| 2020 | 6993 |
| 2019 | 9889 |
| 2018 | 8408 |
| 2017 | 10369 |
| 2016 | 10009 |
| 2015 | 11275 |
| 2014 | 9538 |
Clinical Pharmacology in Drug Development is published by Wiley-Blackwell. It's publishing house is located in United States. Coverage history of this journal is as following: 2012-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Clinical Pharmacology in Drug Development is Clin. Pharmacol. Drug Dev.. This abbreviation ('Clin. Pharmacol. Drug Dev.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmaceutical Science (Q2); Pharmacology (medical) (Q2), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Clinical Pharmacology in Drug Development latest impact IF is 1.86. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 2.15 (2022) and 0.87 (2016), respectively, in the last 10 years. Moreover, its average IS is 1.66 in the previous 10 years.
The Clinical Pharmacology in Drug Development has an SJR (SCImago Journal Rank) of 0.626, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 0.711 in 2020 and the lowest being 0.382 in 2015. Furthermore, the average SJR of the Clinical Pharmacology in Drug Development over the previous 10-year period stands at 1.66.
The latest h-index of the Clinical Pharmacology in Drug Development is 35.
The Clinical Pharmacology in Drug Development is published by the Wiley-Blackwell, with its country of publication being the United States.
The Clinical Pharmacology in Drug Development is currently ranked 8524 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 6993 in 2020 and its lowest position of 11275 in 2015.
The standard ISO4 abbreviation for the Clinical Pharmacology in Drug Development is Clin. Pharmacol. Drug Dev..
Clinical Pharmacology in Drug Development is classified as a journal that the Wiley-Blackwell publishes.
The Clinical Pharmacology in Drug Development encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Clinical Pharmacology in Drug Development is assigned the following International Standard Serial Numbers (ISSN): 21607648, 2160763X.
The best quartile for the Clinical Pharmacology in Drug Development is Q2 (2023).
The Clinical Pharmacology in Drug Development coverage history can be summarized as follows: 2012-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Academic Ethics | journal | 10291 | Springer Netherlands | 30 | 2.62 |
| Historia | journal | 28724 | Universidade Estadual Paulista | 8 | 0.02 |
| Proceedings of the International Symposium on Power Semiconductor Devices and ICs | conference and proceedings | 7015 | 49 | 2.14 | |
| Marine Biology Research | journal | 14120 | Taylor and Francis Ltd. | 45 | 1.02 |
| Sex Education | journal | 7722 | Routledge | 45 | 2.66 |
| Studies in Continuing Education | journal | 7550 | Routledge | 40 | 3.04 |
| Educational Measurement: Issues and Practice | journal | 5979 | Wiley-Blackwell Publishing Ltd | 64 | 1.67 |
| Biological Procedures Online | journal | 4092 | BioMed Central Ltd | 48 | 3.54 |
| Genes and Nutrition | journal | 5793 | BioMed Central Ltd | 65 | 3.42 |
| East African journal of public health | journal | 19634 | East African Public Health Association | 23 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 1.86 |
| 2022 | 2.15 |
| 2021 | 2.13 |
| 2020 | 1.92 |
| 2019 | 1.79 |
| 2018 | 2.13 |
| 2017 | 1.34 |
| 2016 | 0.87 |
| 2015 | 1.18 |
| 2014 | 1.26 |
